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INTRODUCTION
Oral cancer is an important and growing global health 
problem that currently accounts for about 3% of world-
wide malignancies. It is usually synonymous with squa-
mous cell carcinoma of the oral cavity. Most potentially 
malignant disorders are found on the buccal mucosa, 
lower gingiva, tongue, and floor of the mouth, with the 
remaining cases distributed throughout the rest of the 
oral cavity (Epstein et al., 2008). The American Cancer 
Society has estimated that in the United States there 
were 23,000 new cases of oral cancer, with 5,300 deaths, 
in 2010 (Steele and Meyers, 2011). Incidence and mor-
tality are even higher in developing countries, where 
cancer of the oral cavity ranks among the three most 
common types of cancer. In India, the age-standardized 
incidence rate of oral cancer is reported at 12.6 per 
100,000 people (Petersen, 2009). Such staggering num-
bers have led organizations across the globe, including 
the World Health Organization, to take steps to ensure 
that prevention of oral cancer is an integral part of 
national cancer-control programs (Petersen, 2009). 
Despite the increased attention to oral cancer and the 
great strides made in treatment options, the five-year 
survival rate has not changed appreciably in the past 
several decades, remaining at 50–60% since 1974 (Steele 
and Meyers, 2011). One major factor that has prevented 
improvement in the survival rate is that presentation is 
often symptomatic only at a late stage, when five-year 
survival rates are close to 20% (Steele and Meyers, 2011). 
The ability to diagnose oral squamous cell carcinoma at 
early stages is crucial to improving survival rates, qual-
ity of life, and treatment efficacy. Visual inspection and 
physical examination continue to be the predominant 
initial means of screening for oral cancer. In a systematic 
review of the literature, Kujan et al. (2005) concluded 
that there was insufficient evidence either to support or 
to refute the use of screening for oral cancer in the gen-
eral population. However, a randomized trial in India 
of more than 100,000 high-risk patients found a 34% 
reduction in mortality due to oral cancer in people who 
underwent regular visual screening by trained health-
care workers, compared to those who did not undergo 
regular visual screening (Sankaranarayanan et al., 2005). 
Based on these findings, it is evident that the oral cavity 
is an easily accessible site for screening by physicians and 
other healthcare workers in order to detect early oral 
neoplasia. 
Unfortunately, most Americans, particularly popula-
tions at increased risk of oral cancer, do not receive 
routine oral healthcare. It is incumbent upon the medi-
cal community, particularly primary care physicians, to 
conduct opportunistic screenings on high-risk patients 
presenting for healthcare services in nondental settings. 
Although many physicians are not trained to screen for 
oral cancer (Mouradian et al., 2005), this does not imply 
a reluctance to learn about the importance of screen-
ing or to adopt the tools necessary to screen patients. A 
recent pilot study found that after undergoing a one-
day training program, physicians indicated that they 
“definitely intended to change their clinical practice as a 
result of the training” (LeHew et al., 2009). 
This commentary undertakes to review and update the 
risk factors for oral squamous cell cancer, to review the 
nature of oral precancerous lesions, to describe effec-
tive techniques that can be used in screening, and to 
help educate primary care physicians to screen high-
risk patients effectively for oral cancer at early stages 
to decrease mortality and increase the five-year survival 
rate from oral cancer.
EPIDEMIOLOGY OF OROPHARYNGEAL SQUAMOUS CELL 
CARCINOMA
Oral cavity cancer is a major contributor to the global 
burden of cancer (Petersen, 2009). Each year an esti-
mated 263,000 new cases of oral cavity cancer arise 
worldwide, resulting in approximately 127,000 deaths 
(International Agency for Research on Cancer, 2008). 
Oral squamous cell carcinoma is associated with a num-
ber of risk factors, of which tobacco and alcohol use 
present the greatest opportunity for intervention. To 
date it has been difficult to discern the contribution of 
these risk factors to oral cancers because of their asso-
ciated comorbidities. Additionally, several studies have 
shown a synergistic effect of tobacco and excessive use 
of alcohol on the incidence of oropharyngeal squamous 
cell carcinoma (Petersen, 2009). Furthermore, a history 
of prior upper aerodigestive tract cancer confers a nine-
fold increase in the relative risk of subsequent oropha-
ryngeal carcinoma compared to the general population. 
Other known risk factors include betel nut chewing, oral 
human papillomavirus infection, chronic immunosup-
pression following solid organ transplant, hematopoi-
etic cell transplant, and possibly HIV infection and AIDS 
(Warnakulasuriya, 2009). It is essential for the specialist 
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and primary care physician alike to be aware of all the 
risk factors in establishing a patient history.
A number of clinical lesions in the oral cavity have been 
described as premalignant, and are specifically regarded 
as precursors to oral squamous cell carcinoma. These 
include leukoplakia, erythroplakia, dysplastic leukopla-
kia, dysplastic lichenoid lesion, oral submucous fibrosis, 
and lichen planus (Epstein et al., 2008). About 5–18% of 
epithelial dysplasias undergo malignant transformation 
(Axéll et al., 1996). Several factors are associated with 
the increased progression of premalignant lesions to 
cancer: these include color (red, red/white), irregularity 
(lack of homogeneity), surface texture (granular, verru-
cous), and location (floor of the mouth, ventral or pos-
terolateral border of the tongue) (Shiboski et al., 2000). 
Thus, the well-described appearance of premalignant 
lesions in the oral cavity further underscores the value 
of a thorough physical exam.
Estimates suggest that in the year 2011, 39,400 new 
cases of oropharyngeal cancer were diagnosed in the 
United States. In addition, 7,900 deaths were associated 
with oropharyngeal cancer. Despite the ready accessibil-
ity of the oral cavity to direct examination, these malig-
nancies are often still not detected until a late stage and, 
as a result, the survival rate for oral cancer has remained 
essentially unchanged over the past three decades. The 
five-year survival rate for early-stage tumors approaches 
80% but falls below 30% for stage 4 tumors (National 
Cancer Institute, 2011). 
CURRENT GUIDELINES FOR SCREENING
There are currently no definitive guidelines for screening 
for oral cancer. In 2004, the U.S. Preventive Services Task 
Force report found that there was not enough evidence 
to recommend for or against screening for oral cancer 
of smokers older than 50 and those at low risk (U.S. 
Preventive Services Task Force, 2004). Despite the lack 
of evidence to support screening of the general popula-
tion, there is evidence that screening high-risk patients 
does decrease mortality and may be a more viable strat-
egy (Sankaranarayanan et al., 2005). The question often 
arises: which medical providers should be conducting 
these screenings? Early-stage cancers in the oral cavity 
are more often identified by dentists, while late-stage 
disease is more likely to be discovered by medical physi-
cians (LeHew et al., 2009). Unfortunately, many of those 
who are at high risk—smokers, African Americans, men, 
and individuals of low socioeconomic status—will not 
regularly see dentists and will be more likely to have 
late-stage diagnoses. Therefore, incidental screening 
of high-risk patients has been suggested when patients 
are seen for other examinations by healthcare providers. 
Primary care physicians can provide this type of screen-
ing for premalignant and squamous cell carcinomas in 
target individuals.
CONCLUSION
Oral squamous cell carcinoma is a life-threatening dis-
ease with high morbidity and mortality costs. However, 
it is potentially easily detectable; neither heavy and 
expensive machinery nor invasive procedures are 
required to identify early lesions. This easy accessibility 
of the oral cavity to exam renders it an ideal target for 
improved screening practices. Due to the modest invest-
ments of time and cost required by screening exams, 
we recommend that primary care physicians assume a 
frontline role in the battle against oral squamous cell 
cancer. By actively defining those at high risk based on 
the aforementioned risk factors, primary care physicians 
can screen such patients when they come to the office 
and help refer appropriate patients to an otorhinolar-
yngologist. Screening and educating patients about 
lifestyle modifications can help significantly decrease 
the prevalence of and mortality from oral squamous cell 
carcinoma.
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